Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Valneva to Present and Hold Investor Meetings at Upcoming U.S. and European Healthcare Conferences
GlobeNewswire, Inc.
Lyon (France), October 14, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that its senior management will present and participate in meetings with institutional investors at upcoming investor...
Influential Women Profiles: Alejandra Meneses, Expanding Access To Healthcare Education & Supporting Physician Practices
EIN Presswire
LOS ANGELES, CA, UNITED STATES, October 14, 2026 /EINPresswire.com/ -- The Healthcare Program Delivery Manager at InStride and Founder of A.Men Admin, LLC Brings Curiosity, Collaboration, and a Commitment to Equitable Opportunity to Healthcare...
iQor Helps Healthcare Organizations Resolve the Friction Behind Rising Denials and Delays
GlobeNewswire, Inc.
FT. LAUDERDALE, Fla., Oct. 14, 2026 (GLOBE NEWSWIRE) -- iQor, a global leader in customer experience business process outsourcing, today highlighted how its healthcare customer experience (CX) programs help providers, payers and life sciences...
Meghan Correia, Highlighted By Influential Women, Designs Human-Centered Healthcare Experiences Rooted In Deep Empathy
EIN Presswire
BELLINGHAM, MA, UNITED STATES, October 14, 2026 /EINPresswire.com/ -- The Senior Lead UX Designer at Optum Brings Together Art, Behavioral Psychology, and Collaborative Design to Simplify Technology for Healthcare Professionals and Patients...
UK’s Healthcare Marketing Specialist Rebuilds Itself With AI
EIN Presswire
The UK healthcare marketing specialist pairs an AI-driven build with human-led design direction in a full rebrand of pulsedigital.health LONDON, UNITED KINGDOM, October 14, 2026 /EINPresswire.com/ -- Pulse Digital Health, the UK’s...
Ultragenyx Enters into Agreement to Sell Rare Pediatric Disease Priority Review Voucher for $203 Million
GlobeNewswire, Inc.
NOVATO, Calif., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced that it has entered into a definitive agreement to sell a Rare Pediatric Disease Priority Review Voucher (PRV) for $203 million....
Prestige Consumer Healthcare to Release Fiscal 2027 Second Quarter Earnings Results
GlobeNewswire, Inc.
TARRYTOWN, N.Y., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2027 second quarter and first half earnings release on Thursday, November 5, 2026 before the opening of...
Alignment Healthcare to Announce Third Quarter 2026 Financial Results and Host Conference Call Thursday, Oct. 29, 2026
GlobeNewswire, Inc.
ORANGE, Calif., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), will release its third quarter 2026 financial results on Thursday, Oct. 29, 2026, after market close.
The future NHS depends on the doctors we train today
Royal College of Physicians
The NHS is facing a period of profound change.
Navy SEAL Veteran Evan Shelline Chairs First-of-Its-Kind Veteran Advisory Committee at Lily Hospice
EIN Presswire
Former Navy Corpsman Simone Luu, RN, is co-chair and clinical leader.
Orvida Pharma Announces FDA Acceptance of KM-023 (ontivatrep) into Rare Disease Evidence Principles Process for Olmsted Syndrome
GlobeNewswire, Inc.
FDA’s Rare Disease Evidence Principles (RDEP) process aims to provide greater speed and predictability in the review of therapies for rare diseases with significant unmet medical need Acceptance enables engagement with FDA on the data needed to...
Arexera Therapeutics, Formerly Atalanta Therapeutics, Unveils New Corporate Identity and Advances Huntington's Disease Franchise
GlobeNewswire, Inc.
- Proprietary siRNA platforms, designed to enable robust and durable gene silencing throughout the brain, support a differentiated Huntington’s disease franchise and broader neurological disease pipeline focused on genetically validated drivers of...
Together, We Move: Alloy Employer Services to Unveil Bold New Brand at Nationwide Children’s Hospital Columbus Half Marathon
GlobeNewswire, Inc.
COLUMBUS, Ohio, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Alloy Employer Services (Alloy), an integrated risk solution provider founded in Ohio that helps employers build safer, healthier workplaces, today announced the launch of a new brand identity...
Carrington College Invites Community to Explore Healthcare Programs at Open House on October 21
GlobeNewswire, Inc.
SACRAMENTO, Calif., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Carrington College campuses will host an Open House on Wednesday, Oct. 21, from 4-7 p.m., inviting prospective students and community members to explore its programs in medical, dental,...
SAB BIO to Participate in Chardan 10th Annual Healthcare Conference
GlobeNewswire, Inc.
MIAMI, Oct. 14, 2026 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing a fully human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and other autoimmune diseases,...
Discovery Health expanded access to mental healthcare for 22,000 members in one year, with better outcomes and lower hospital costs
GlobeNewswire, Inc.
BOSTON and JOHANNESBURG, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of technology-enabled care, today published a new case study on Discovery Health’s use of SilverCloud® by Amwell® to deliver a fully funded digital...
CAMP4 to Participate in Chardan’s 10th Annual Healthcare Conference
GlobeNewswire, Inc.
WATERTOWN, Mass., Oct. 14, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting therapeutics designed to upregulate gene...
Century Therapeutics to Attend 2026 Jefferies Global Healthcare Conference in London
GlobeNewswire, Inc.
PHILADELPHIA, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), a biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies for type 1 diabetes (T1D) and other autoimmune...
BioVie to Present New Bezisterim Findings in Parkinson’s Disease and Long COVID at the 2026 American Neurological Association Annual Meeting
GlobeNewswire, Inc.
CARSON CITY, Nev., Oct. 14, 2026 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and neurodegenerative diseases, today announced that two...
Tvardi Therapeutics to Participate in Chardan’s 10th Annual Healthcare Conference
GlobeNewswire, Inc.
HOUSTON, Oct. 14, 2026 (GLOBE NEWSWIRE) -- Tvardi Therapeutics, Inc. (“Tvardi” or the “Company”) (NASDAQ: TVRD), a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat...
Sign up for:
Today in Healthcare
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.